© SYMYOO Inc. All rights reserved.
Symyoo was designated as a global coordinating center to run late phase multinational clinical trials for Covid-19 medication development. The trials are conducted widely across Korea and European countries. Symyoo understands well that the trial operations should be very specific to the risk and complexity of each region/country where the trials are conducted.
Established Symyoo America, Inc. in order to provide global trial consulting services for the Korean pharmaceutical, biotechnology and life-science companies wishing to enter the global market.
Symyoo EDC system, SYNeRA™, expanded its functionalities by integrating new modules, including IWRS (Interactive Web-based Randomization System), IP Accountability (Investigational Product Tracking and Management System), and RBM (Risk-Based Monitoring System). Symyoo IWRS can handle various randomization algorithms from simple permuted block randomization to very complex covariate adaptive randomization (biased coin, minimum sufficient).
Symyoo participated in Korea CDISC Coordinating Committee (K3C) and achieved CDISC/SCDM industry partnership, which is granted to a company having comprehensive data management capability for clinical research.
Conducted more than 150 clinical studies, including 30 oncology trials over 9 years since its foundation in 2009. Symyoo had been coordinating and collaborating with various
Launched Symyoo EDC system, SYNeRA™ for clinical research data collection and management. Symyoo SMART TRIALS research center continues to develop and expand SYNeRA™ functionalities into a web-based Comprehensive Clinical Trial Management System.
Began research collaboration with Global Clinical Trial Center of Anam Hospital, Korea University Medical Center
Qualified for full membership in Korea Clinical Trial CRO Association.
Established SMART TRIALS center to research and facilitate new IT technologies for tomorrow’s medicines. Symyoo reorganized data management and biostatistics team to offer broader data management services.
Partnership contract with Clinical Trial Center of Baek University Hospital, Inje University